|
EIF2AK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.137600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.041000E-01 |
| Normal-vs-Stage2 |
2.867400E-01 |
| Normal-vs-Stage3 |
7.847600E-02 |
| Normal-vs-Stage4 |
8.835500E-02 |
| Stage1-vs-Stage2 |
7.603600E-01 |
| Stage1-vs-Stage3 |
3.869200E-01 |
| Stage1-vs-Stage4 |
4.203800E-01 |
| Stage2-vs-Stage3 |
8.344800E-01 |
| Stage2-vs-Stage4 |
8.387800E-01 |
| Stage3-vs-Stage4 |
9.887200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.234600E-01 |
| Normal-vs-AfricanAmerican |
7.5684999999992E-05 |
| Normal-vs-Asian |
4.778200E-01 |
| Caucasian-vs-AfricanAmerican |
1.437430E-04 |
| Caucasian-vs-Asian |
2.877200E-01 |
| AfricanAmerican-vs-Asian |
7.020200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.695700E-02 |
| Normal-vs-Female |
4.860800E-01 |
| Male-vs-Female |
7.712300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.949610E-01 |
| Normal-vs-Age(41-60Yrs) |
1.702230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.395450E-01 |
| Normal-vs-Age(81-100Yrs) |
1.356820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.728000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.270600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.719600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.162200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.630200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.657800E-01 |
| Normal-vs-Grade 2 |
4.066000E-01 |
| Normal-vs-Grade 3 |
1.070070E-02 |
| Normal-vs-Grade 4 |
2.049600E-01 |
| Grade 1-vs-Grade 2 |
5.557400E-01 |
| Grade 1-vs-Grade 3 |
1.121960E-01 |
| Grade 1-vs-Grade 4 |
3.511200E-01 |
| Grade 2-vs-Grade 3 |
3.675900E-02 |
| Grade 2-vs-Grade 4 |
5.120000E-01 |
| Grade 3-vs-Grade 4 |
4.350600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.258000E-01 |
| Normal-vs-ccB subtype |
1.272000E-01 |
| ccA subtype-vs-ccB subtype |
6.339900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.953800E-01 |
| Normal-vs-N1 |
8.303000E-01 |
| N0-vs-N1 |
7.888400E-01 |
|
|
